3-44594687-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_173658.4(ZNF660):āc.494T>Cā(p.Ile165Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000236 in 1,611,976 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_173658.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF660 | ENST00000322734.2 | c.494T>C | p.Ile165Thr | missense_variant | 3/3 | 2 | NM_173658.4 | ENSP00000324605.2 | ||
ZNF197 | ENST00000412641.1 | c.-82+8474T>C | intron_variant | 2 | ENSP00000394713.1 | |||||
ZKSCAN7-AS1 | ENST00000457331.2 | n.233-37095A>G | intron_variant | 3 | ||||||
ZKSCAN7-AS1 | ENST00000685649.2 | n.225-33094A>G | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.0000133 AC: 2AN: 150100Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000123 AC: 31AN: 251456Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135902
GnomAD4 exome AF: 0.0000246 AC: 36AN: 1461876Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 727240
GnomAD4 genome AF: 0.0000133 AC: 2AN: 150100Hom.: 0 Cov.: 32 AF XY: 0.0000136 AC XY: 1AN XY: 73314
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 26, 2022 | The c.494T>C (p.I165T) alteration is located in exon 3 (coding exon 1) of the ZNF660 gene. This alteration results from a T to C substitution at nucleotide position 494, causing the isoleucine (I) at amino acid position 165 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at